Dogwood Therapeutics annual shares outstanding
2020
2021
2022
2023
2024
2025
Dogwood Therapeutics Shares Outstanding History (DWTX)
Dogwood Therapeutics reported 29.7M shares outstanding at the end of fiscal 2025.
View full Dogwood Therapeutics company overviewDogwood Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 29.7M | 28.4M | +2132.70% |
| 2024 | 2024-12-31 | 1.3M | 561,861 | +72.94% |
| 2023 | 2023-12-31 | 770,317 | 37,101.4 | +5.06% |
| 2022 | 2022-12-31 | 733,215.6 | 400,000 | +120.04% |
| 2021 | 2021-12-31 | 333,215.6 | 1,012.6 | +0.30% |
| 2020 | 2020-12-31 | 332,203 | — | — |
Dogwood Therapeutics quarterly shares outstanding
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 33.6M | 31.7M | +1659.67% |
| Q1 2026 | 2026-03-31 | 33.4M | 31.5M | +1647.74% |
| Q4 2025 | 2025-12-31 | 29.7M | 28.4M | +2132.70% |
| Q3 2025 | 2025-09-30 | 2.3M | 2.2M | +5063.30% |
| Q2 2025 | 2025-06-30 | 1.9M | 800,810.52 | +72.12% |
| Q1 2025 | 2025-03-31 | 1.9M | 800,810.52 | +72.12% |
| Q4 2024 | 2024-12-31 | 1.3M | 561,860.52 | +72.94% |
| Q3 2024 · Sep 30 | 2024-09-30 | 44,412.68 | −725,904.8 | −94.23% |
| Q3 2024 · Sep 29 | 2024-09-29 | 1.1M | 340,000 | +44.14% |
| Q2 2024 | 2024-06-30 | 1.1M | 377,101.88 | +51.43% |
| Q1 2024 | 2024-03-31 | 770,317.48 | 37,101.88 | +5.06% |
| Q4 2023 | 2023-12-31 | 770,317.48 | 37,101.88 | +5.06% |
| Q3 2023 | 2023-09-30 | 770,317.48 | 37,101.88 | +5.06% |
| Q2 2023 | 2023-06-30 | 733,215.6 | 400,000 | +120.04% |
| Q1 2023 | 2023-03-31 | 733,215.6 | 400,000 | +120.04% |
| Q4 2022 | 2022-12-31 | 733,215.6 | 400,000 | +120.04% |
| Q3 2022 | 2022-09-30 | 733,215.6 | 400,000 | +120.04% |
| Q2 2022 | 2022-06-30 | 333,215.6 | 0 | 0.00% |
| Q1 2022 | 2022-03-31 | 333,215.6 | 0 | 0.00% |
| Q4 2021 | 2021-12-31 | 333,215.6 | 1,012.6 | +0.30% |
| Q3 2021 | 2021-09-30 | 333,215.6 | — | — |
| Q2 2021 | 2021-06-30 | 333,215.6 | — | — |
| Q1 2021 | 2021-03-31 | 333,215.6 | — | — |
| Q4 2020 | 2020-12-31 | 332,203 | — | — |
Dogwood Therapeutics shares outstanding trends
Over the last five reported fiscal years, Dogwood Therapeutics's shares outstanding moved from 332,203 to 29.7M, a change of 29.4M. The latest reported quarter, Q2 2026, shows 33.6M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dogwood Therapeutics filings at SEC.gov ↗